Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism

In the present study, the authors performed genome-wide SNP typing of 55 Malagasy samples with the Infinium Multi-Ethnic Genotyping Array (MEGA) and analyzed data with a focus on a set of 28 pharmacogenes (Supplementary Table 1).QC steps were followed as recommended by Illumina [42,45] and have been...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Y Cramer, Estee, Bartlett, Jacquelaine, R Chan, Ernest, Gaedigk, Andrea, Ratsimbasoa, Arsene C., Mehlotra, Rajeev K., M Williams, Scott, Zimmerman, Peter A.
Format: Dataset
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Y Cramer, Estee
Bartlett, Jacquelaine
R Chan, Ernest
Gaedigk, Andrea
Ratsimbasoa, Arsene C.
Mehlotra, Rajeev K.
M Williams, Scott
Zimmerman, Peter A.
description In the present study, the authors performed genome-wide SNP typing of 55 Malagasy samples with the Infinium Multi-Ethnic Genotyping Array (MEGA) and analyzed data with a focus on a set of 28 pharmacogenes (Supplementary Table 1).QC steps were followed as recommended by Illumina [42,45] and have been described by various authors [46,47] (Supplementary Document 1). The MAF distribution of the polymorphic SNPs in four classes (rare, 5–10%; and high, >10%) is presented in Supplementary Table 2For the polymorphic SNPs, their locations, SNP IDs, genomic sequence positions and variant impacts, the star alleles/suballeles they represent and their MAFs, are presented in Supplementary Table 3 in chromosomal order.The majority of these SNPs are intronic (n = 384), whereas 110 are in coding regions or impact splicing; the latter are presented separately in Supplementary Table 4.Their distribution, CNV confidence scores and sizes are presented in Supplementary Table 5.The same CNVs were identified in more than one Malagasy sample; examples and selected results are presented in Supplementary Table 6
doi_str_mv 10.25402/pgs.23904450
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_25402_pgs_23904450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_25402_pgs_23904450</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_25402_pgs_239044503</originalsourceid><addsrcrecordid>eNqVjrsOwjAMRbMwIGBk9w-0pKUdYEUgFiQG9si0aWspL5IUqX9PFcEHMFm2z706jG0Lnpd1xcud60Ne7g-8qmq-ZP4-oNfY2F4aq6mBN3rCSNYAGYiDhBsq7DFM4KwbVXodgbRT1KQlQGd9ItFE0jM9Fyho_diD8_PhNZKRoGXEp1UU9JotOlRBbr5zxbLL-XG6Zi1GbChKkWJ-EgUXyVnMzuLnvP-X_wAphlIh</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism</title><source>DataCite</source><creator>Y Cramer, Estee ; Bartlett, Jacquelaine ; R Chan, Ernest ; Gaedigk, Andrea ; Ratsimbasoa, Arsene C. ; Mehlotra, Rajeev K. ; M Williams, Scott ; Zimmerman, Peter A.</creator><creatorcontrib>Y Cramer, Estee ; Bartlett, Jacquelaine ; R Chan, Ernest ; Gaedigk, Andrea ; Ratsimbasoa, Arsene C. ; Mehlotra, Rajeev K. ; M Williams, Scott ; Zimmerman, Peter A.</creatorcontrib><description>In the present study, the authors performed genome-wide SNP typing of 55 Malagasy samples with the Infinium Multi-Ethnic Genotyping Array (MEGA) and analyzed data with a focus on a set of 28 pharmacogenes (Supplementary Table 1).QC steps were followed as recommended by Illumina [42,45] and have been described by various authors [46,47] (Supplementary Document 1). The MAF distribution of the polymorphic SNPs in four classes (rare, &lt;1%; low, 1–5%; moderate, &gt;5–10%; and high, &gt;10%) is presented in Supplementary Table 2For the polymorphic SNPs, their locations, SNP IDs, genomic sequence positions and variant impacts, the star alleles/suballeles they represent and their MAFs, are presented in Supplementary Table 3 in chromosomal order.The majority of these SNPs are intronic (n = 384), whereas 110 are in coding regions or impact splicing; the latter are presented separately in Supplementary Table 4.Their distribution, CNV confidence scores and sizes are presented in Supplementary Table 5.The same CNVs were identified in more than one Malagasy sample; examples and selected results are presented in Supplementary Table 6</description><identifier>DOI: 10.25402/pgs.23904450</identifier><language>eng</language><publisher>Taylor &amp; Francis</publisher><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.25402/pgs.23904450$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Y Cramer, Estee</creatorcontrib><creatorcontrib>Bartlett, Jacquelaine</creatorcontrib><creatorcontrib>R Chan, Ernest</creatorcontrib><creatorcontrib>Gaedigk, Andrea</creatorcontrib><creatorcontrib>Ratsimbasoa, Arsene C.</creatorcontrib><creatorcontrib>Mehlotra, Rajeev K.</creatorcontrib><creatorcontrib>M Williams, Scott</creatorcontrib><creatorcontrib>Zimmerman, Peter A.</creatorcontrib><title>Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism</title><description>In the present study, the authors performed genome-wide SNP typing of 55 Malagasy samples with the Infinium Multi-Ethnic Genotyping Array (MEGA) and analyzed data with a focus on a set of 28 pharmacogenes (Supplementary Table 1).QC steps were followed as recommended by Illumina [42,45] and have been described by various authors [46,47] (Supplementary Document 1). The MAF distribution of the polymorphic SNPs in four classes (rare, &lt;1%; low, 1–5%; moderate, &gt;5–10%; and high, &gt;10%) is presented in Supplementary Table 2For the polymorphic SNPs, their locations, SNP IDs, genomic sequence positions and variant impacts, the star alleles/suballeles they represent and their MAFs, are presented in Supplementary Table 3 in chromosomal order.The majority of these SNPs are intronic (n = 384), whereas 110 are in coding regions or impact splicing; the latter are presented separately in Supplementary Table 4.Their distribution, CNV confidence scores and sizes are presented in Supplementary Table 5.The same CNVs were identified in more than one Malagasy sample; examples and selected results are presented in Supplementary Table 6</description><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2023</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqVjrsOwjAMRbMwIGBk9w-0pKUdYEUgFiQG9si0aWspL5IUqX9PFcEHMFm2z706jG0Lnpd1xcud60Ne7g-8qmq-ZP4-oNfY2F4aq6mBN3rCSNYAGYiDhBsq7DFM4KwbVXodgbRT1KQlQGd9ItFE0jM9Fyho_diD8_PhNZKRoGXEp1UU9JotOlRBbr5zxbLL-XG6Zi1GbChKkWJ-EgUXyVnMzuLnvP-X_wAphlIh</recordid><startdate>20230808</startdate><enddate>20230808</enddate><creator>Y Cramer, Estee</creator><creator>Bartlett, Jacquelaine</creator><creator>R Chan, Ernest</creator><creator>Gaedigk, Andrea</creator><creator>Ratsimbasoa, Arsene C.</creator><creator>Mehlotra, Rajeev K.</creator><creator>M Williams, Scott</creator><creator>Zimmerman, Peter A.</creator><general>Taylor &amp; Francis</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20230808</creationdate><title>Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism</title><author>Y Cramer, Estee ; Bartlett, Jacquelaine ; R Chan, Ernest ; Gaedigk, Andrea ; Ratsimbasoa, Arsene C. ; Mehlotra, Rajeev K. ; M Williams, Scott ; Zimmerman, Peter A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_25402_pgs_239044503</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Y Cramer, Estee</creatorcontrib><creatorcontrib>Bartlett, Jacquelaine</creatorcontrib><creatorcontrib>R Chan, Ernest</creatorcontrib><creatorcontrib>Gaedigk, Andrea</creatorcontrib><creatorcontrib>Ratsimbasoa, Arsene C.</creatorcontrib><creatorcontrib>Mehlotra, Rajeev K.</creatorcontrib><creatorcontrib>M Williams, Scott</creatorcontrib><creatorcontrib>Zimmerman, Peter A.</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Y Cramer, Estee</au><au>Bartlett, Jacquelaine</au><au>R Chan, Ernest</au><au>Gaedigk, Andrea</au><au>Ratsimbasoa, Arsene C.</au><au>Mehlotra, Rajeev K.</au><au>M Williams, Scott</au><au>Zimmerman, Peter A.</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism</title><date>2023-08-08</date><risdate>2023</risdate><abstract>In the present study, the authors performed genome-wide SNP typing of 55 Malagasy samples with the Infinium Multi-Ethnic Genotyping Array (MEGA) and analyzed data with a focus on a set of 28 pharmacogenes (Supplementary Table 1).QC steps were followed as recommended by Illumina [42,45] and have been described by various authors [46,47] (Supplementary Document 1). The MAF distribution of the polymorphic SNPs in four classes (rare, &lt;1%; low, 1–5%; moderate, &gt;5–10%; and high, &gt;10%) is presented in Supplementary Table 2For the polymorphic SNPs, their locations, SNP IDs, genomic sequence positions and variant impacts, the star alleles/suballeles they represent and their MAFs, are presented in Supplementary Table 3 in chromosomal order.The majority of these SNPs are intronic (n = 384), whereas 110 are in coding regions or impact splicing; the latter are presented separately in Supplementary Table 4.Their distribution, CNV confidence scores and sizes are presented in Supplementary Table 5.The same CNVs were identified in more than one Malagasy sample; examples and selected results are presented in Supplementary Table 6</abstract><pub>Taylor &amp; Francis</pub><doi>10.25402/pgs.23904450</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.25402/pgs.23904450
ispartof
issn
language eng
recordid cdi_datacite_primary_10_25402_pgs_23904450
source DataCite
title Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T09%3A46%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Y%20Cramer,%20Estee&rft.date=2023-08-08&rft_id=info:doi/10.25402/pgs.23904450&rft_dat=%3Cdatacite_PQ8%3E10_25402_pgs_23904450%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true